Trump again puts Greenland in the crosshairs: “It should be under United States control”
You might be interested in Possible betrayal of Raphinha: his father would have swindled him out of a…
Oral Wegovy’s UK Rollout Puts Novo Nordisk’s Pivot to the Pill to the Test
Novo Nordisk’s long-anticipated shift from injection to tablet enters its most public phase this week, with the oral…
Novo Nordisk Puts 5 Billion DKK Behind Its Stock as Pipeline Wins Offset Cyber Setback
The Danish pharmaceutical giant has endured a week of stark contrasts, threading clinical breakthroughs, a regulatory milestone, and…
Berlin Schools Bleed 2,668 Teachers as German Court Puts Public Duty Ahead of Private Wants
A recent administrative court ruling in Gelsenkirchen highlights the mounting tension between personal convenience and the urgent need…
Hensoldt’s 10% Weekly Drop Puts ILA Berlin and KNDS IPO in the Spotlight
Hensoldt shares fall 10.5% in a week as defense capital rotates to upcoming KNDS IPO; China export controls…
Wegovy Pill’s Gulf Debut Puts Novo Nordisk’s Global Ambitions to the Test Amid Competitive Press
Novo Nordisk expands oral Wegovy to UAE, targeting a vast untapped obesity market. Shares remain under pressure from…
Novo Nordisk Puts Oral Ozempic on Pharmacy Shelves Just Days Before a Make-or-Break Earnings Report
Novo Nordisk rolls out oral semaglutide as Ozempic in US pharmacies, facing revenue decline, pricing pressure, and fierce…
A$24 Million Cash Gap Puts European Lithium’s Greenland Merger on a Knife-Edge
European Lithium must plug a A$24 million cash shortfall by May 7 or risk losing its A$835 million…
Greenland Rare Earths Consolidation Puts European Lithium on the Clock to Fill a A$24 Million Gap
European Lithium must raise A$24M by May 7 to complete a US$835M all-share merger with Critical Metals, targeting…
Political Gridlock Puts Ørsted’s Ownership in the Balance
Political deadlock threatens Denmark’s controlling stake in Ørsted as the company completes a major divestment program and plans…